Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities
Go back to Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities| (NASDAQ: CLBT) | Delayed: 11.55 -0.3 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.85 | 52 Week High | $ | |||
| Open | $11.86 | 52 Week Low | $ | |||
| Day High | $11.97 | P/E | N/A | |||
| Day Low | $11.40 | EPS | $ | |||
| Volume | 1,008,261 | |||||
| (NASDAQ: CLBTW) | Delayed: 5.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.25 | 52 Week High | $ | |||
| Open | $5.25 | 52 Week Low | $ | |||
| Day High | $5.25 | P/E | N/A | |||
| Day Low | $5.25 | EPS | $ | |||
| Volume | 2,023 | |||||
